Philadelphia Eagles quarterback Jalen Hurts will miss the remainder of the season after suffering bilateral pulmonary emboli. The NFL and the NFLPA are now investigating the medical decisions that allowed Hurts to play in a London game despite a known blood clot.
From an October 8 calf injury to a London hospital bed
The medical timeline for Jalen Hurts suggests a rapid and dangerous escalation of a treatable conidtion. According to the report, Hurts first notified Philadelphia Eagles medical personnel of calf pain on October 8, following a collision with a cleat during practice. While Danish and British specialists initially diagnosed a superficial vein thrombosis, the Philadelphia Eagles chose to keep the quarterback active for the October 11 game against the Jacksonville Jaguars in London.
This decision proved catastrophic. as the report indicates, subsequent imaging revealed that the blood clot had not remained superficial; instead, it deepened and migrated from the left calf into the lungs. This progression necessitated immediate hospitalization and the administration of blood thinners, which effectively ended Jalen Hurts' season. The transition from a localized calf issue to a life-threatening pulmonary complication raises significant questions about the risks associated with long-haul flights for athletes with vascular injuries.
Article 39, Section 5(f) and the NFLPA's demand for transparency
The NFL Players Association (NFLPA) has moved beyond mere concern, formally invoking Article 39, Section 5(f) of the collective bargaining agreement to launch an investigation. The union is specifically questioning why Jalen Hurts was permitted to travel to London while under treatment for a thrombosis. This move signals a lack of confidence in the league's internal oversight regarding player safety during international series games .
NFL Commissioner Jerome Allen Sills has publicly defended the process, claiming that the league's chief medical officer approved the Philadelphia Eagles' actions and that the protocols used were "very conservative." However, the NFLPA's decision to trigger a formal CBA investigation suggests a fundamental disagreement over what constitutes "conservative" care when a player's life is potentially at risk .
The silence of Howie Roseman and the mystery of the medical staff
A glaring void in the current narrative is the lack of communication from the Philadelphia Eagles' leadership. While head coach Nick Sirianni has provided brief comments, General Manager Howie Roseman has remained entirely silent regarding the management of Jalen Hurts. Furthermore, the specific doctors who evaluated Hurts in London have not been identified or released to the press, fueling speculation about the depth of the initial assessment.
This silence leaves several critical questions unanswered. It remains unknown exactly what the Danish and British specialists advised the Philadelphia Eagles before the Jacksonville Jaguars game. Additionally, there is no public record of whether Jalen Hurts was fully informed of the risks of pulmonary embolism before agreeing to fly to London and compete. Without the testimony of the medical staff or a statement from Howie Roseman, the public is left to wonder if the drive for victory overshadowed clinical caution.
ADA privacy concerns versus the public's right to know
The fallout from this injury has sparked a legal debate over the Americans with Disabilities Act (ADA) and patient confidentiality. The Philadelphia Eagles released a joint statement detailing the evolution of the blood clots, but critics argue that this level of specificity may have violated Jalen Hurts' privacy rights. The tension lies between the team's desire for transparency and the legal obligations to protect a player's sensitive medical records.
Some stakeholders argue that because Jalen Hurts is a public figure and a cornerstone of the league's brand, the public deserves a full accounting of the diagnostic procedures used. Conversely, legal experts warn that disclosing medical details to appease fans or the media could set a dangerous precedent, potentially infringing on the privacy protections guaranteed to all employees under the ADA. This conflict highlights the precarious balance the NFL must strike between corporate transparency and individual health privacy.
Comments 0